Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$115.19 - $132.77 $95,146 - $109,668
-826 Reduced 56.31%
641 $77,000
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $2,318 - $2,760
-19 Reduced 1.28%
1,467 $190,000
Q2 2023

Aug 15, 2023

SELL
$122.5 - $147.16 $127,890 - $153,635
-1,044 Reduced 41.26%
1,486 $184,000
Q4 2022

Feb 15, 2023

BUY
$129.72 - $159.85 $2,464 - $3,037
19 Added 0.76%
2,530 $403,000
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $136,843 - $174,235
1,081 Added 75.59%
2,511 $335,000
Q2 2022

Aug 15, 2022

BUY
$141.59 - $168.66 $64,848 - $77,246
458 Added 47.12%
1,430 $223,000
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $28,131 - $34,871
217 Added 28.74%
972 $151,000
Q4 2021

Feb 15, 2022

SELL
$119.87 - $145.67 $17,141 - $20,830
-143 Reduced 15.92%
755 $96,000
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $15,436 - $22,174
-120 Reduced 11.79%
898 $117,000
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $163,083 - $189,775
1,018 New
1,018 $181,000
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $64,304 - $75,427
-457 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $43,725 - $55,699
457 New
457 $50,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Vestcor Inc Portfolio

Follow Vestcor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.